findmyKOL

Gina Mentzer, MD

Basic profile

Cardiovascular Disease

ORCIDNone on fileNPI↗
✓ Full record
RegionLincoln, NE · MidwestSpecialtyCardiovascular DiseaseFocusCardiology
Active KOLfindmyKOL type: RegionalLatest publication2021Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Gina Mentzer is a Cardiology physician. OpenAlex indexes 13 publications with 237 citations (h-index 3).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
13publications

Distinct works indexed by OpenAlex.

237citations

Total citations across indexed works.

3h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
44companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

2000 Q St
Suite 500
Lincoln, NE 685033609

Telephone

402-328-4572

Registry record last updated 7 Mar 2023.

View the NPPES registry record

Industry payments

44 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    83.5%
    Beta blocker24.3%
    Metoprolol Succinate44%Carvedilol21%Sotalol10%Metoprolol Tartrate10%Bisoprolol Fumarate8%Nebivolol Hcl4%Atenolol2%Propranolol Hcl1%
    Part D<11 patients
    Loop diuretic11.4%
    Furosemide63%Torsemide37%
    Part D≥88 patients

    + 17 more classes in this area

  • Blood & clotting

    10%
    Factor Xa inhibitor6.1%
    Eliquis66%Xarelto34%
    Part D≥35 patients
    P2Y12 inhibitor3.9%
    Clopidogrel100%
    Part D≥48 patients
  • Metabolism & gastrointestinal

    5.9%
    Potassium supplement2.3%
    Potassium Chloride100%
    Part D≥30 patients
    SGLT2 inhibitor1.7%
    Jardiance55%Farxiga45%
    Part D<11 patients

    + 2 more classes in this area

Where care is delivered (Part B)74.1% facility · 25.9% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”